ObsEva Announces Application for a Moratorium to Facilitate Pivotal Deals
November 30, 2023 01:00 ET
|
ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – November 30, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for...
Clean Energy Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
November 28, 2023 08:30 ET
|
Clean Energy Technologies, Inc.
- For the nine months ended September 30, 2023, revenues of $11.7 million represent an increase of 339% compared to $2.6 million for the same period in 2022 COSTA MESA, CA., Nov. 28, 2023 ...
GeoJunxion NV (ticker: GOJXN.AS) - Financiële en Operationele update Q1 FY 2023-24 (juli – september 2023)
November 16, 2023 02:00 ET
|
GeoJunxion N.V.
Capelle aan den IJssel, 16 november 2023, GeoJunxion kondigt de publicatie aan van de financiële resultaten voor de eerste drie maanden van het boekjaar 2023-24, waaruit de eerste tekenen blijken van...
GeoJunxion NV (ticker: GOJXN.AS) - Financial & Business update Q1 FY 2023-24 (July – September 2023)
November 16, 2023 02:00 ET
|
GeoJunxion N.V.
Capelle aan den IJssel, 16 November 2023, GeoJunxion announces the publication of its financial results for the first three months of the accounting year 2023-24, showing first evidence of slowdown in...
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
November 14, 2023 16:04 ET
|
SeaStar Medical Holding Corporation
DENVER, Nov. 14, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company developing proprietary solutions to reduce...
IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update
November 14, 2023 08:00 ET
|
Imunon, Inc.
Advances Non-Viral DNA-Mediated Cancer Immunotherapy and Next-Generation Vaccine Programs, with More Potent and Durable Immunity, with Multiple Near-Term Milestones Conference Call Begins...
Celyad Oncology reports third quarter 2023 financial results and recent business highlights
November 09, 2023 01:00 ET
|
Celyad Oncology SA
Publication of data detailing the development of our microRNA (miRNA)-based multiplex shRNA approach, which allows to down-regulate several genes simultaneously, in Molecular Therapy – Nucleic...
IMUNON to Hold Third Quarter 2023 Financial Results and Business Update Conference Call on Tuesday, November 14, 2023
November 07, 2023 08:30 ET
|
Imunon, Inc.
LAWRENCEVILLE, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation...
Coffee Holdings Co., Inc. Issues Business Update Following 2023 Annual Meeting
November 03, 2023 08:00 ET
|
Coffee Holding Co., Inc.
STATEN ISLAND, New York, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Coffee Holding Co., Inc. (Nasdaq: JVA) (the “Company”) today provided a business update following its 2023 Annual Meeting held on October...
ONWARD Schedules Webcast to Provide Third Quarter 2023 Business Update
October 11, 2023 13:43 ET
|
ONWARD Medical NV
Eindhoven, Netherlands, Oct. 11, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and...